Sound Bioventures (investor - Venture Capital)

See something wrong or missing? Let us know

Offices:Malmö

Sound Bioventures is a venture capital fund from Sweden investing in about-to-be clinical or clinical stage private companies in Europe and USA developing therapies in specialty therapeutics areas

Average round investment:28.91M USD

Average number per year:2.2

Distribution: 2025 (1)2024 (3)2023 (4)2022 (1)

Portfolio companies: Spain

Arthex Biotech S.L. Sweden

AnaCardio

Breye Therapeutics See the entire list

Mostly invests in: Denmark

Denmark (3) Health services (9)

See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sound Bioventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sound Bioventures

Name		Criteria
	AXA IM 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Spain, Sweden, United Kingdom, France Average number of deals per year: 2.2 Active last 12 months: Yes
	Trill Impact 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Sweden, United Kingdom, France Average number of deals per year: 2.2 Active last 12 months: Yes
	Ventura Capital 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 2.3 Active last 12 months: Yes
	Relyens Group 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma, Manufacturing Similar business models: B2B Common investees countries: France Average number of deals per year: 2.2 Active last 12 months: Yes
	Accenture 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing Similar business models: B2B Common investees countries: United Kingdom, France Average number of deals per year: 2.0 Active last 12 months: Yes
	Hostplus 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 2.0 Active last 12 months: Yes
	IPGL 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma, Manufacturing Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 2.5 Active last 12 months: Yes
	Palo Santo 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: United Kingdom Average number of deals per year: 2.0 Active last 12 months: Yes
	CE-Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing Similar business models: B2B Common investees countries: Denmark, France Average number of deals per year: 2.0 Active last 12 months: Yes
	Achilles Capital 83%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Manufacturing Similar business models: B2B Common investees countries: Sweden Average number of deals per year: 2.0 Active last 12 months: Yes

Menu

Sound Bioventures (investor - Venture Capital)

Showing 3 of 9 tracked investments in:

Sound Bioventures mostly invests with:

Investors with similar profile to Sound Bioventures

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe